Skip to content
Friday, March 24, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • <strong>OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh</strong>
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • <strong>Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care</strong>
  • Macra supports Ministry of Health with US$53,296 cholera materials
  • KFSH&RC to debut its Digital Health Conference in Riyadh
  • NPHCDA launches project to prevent maternal health challenges
  • <strong>Saudi’s KAEC inks health cooperation pact with Dr. Sulaiman Al Habib Medical Group</strong>
  • Africa has the highest global surge in oral diseases - WHO
You are here
  • Home
  • Pfizer

Tag: Pfizer

Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care

23 March 202323 March 2023

UAE – State-owned Dubai Academic Health Corporation (DAHC), AXDEV Group, and Pfizer have signed a public-private partnership for improving chronic disease management. It follows the emerging trends of world-class healthcare…

Read More

Pfizer recalls over 4 million packages of prescription migraine medicine voluntarily

19 March 202319 March 2023

USA — Pfizer has issued a recall for 4.2 million packages of Nurtec ODT, which is used to treat migraines in adults. The U.S. Consumer Product Safety Commission (CPSC) raised…

Read More

FDA advisory panel supports full approval of Pfizer’s COVID therapy

17 March 202317 March 2023

USA —Advisers to the U.S. Food and Drug Administration gave strong support for full approval of Pfizer’s oral antiviral COVID-19 treatment, Paxlovid, for adults at high risk of severe disease…

Read More

Pfizer, Biovac launch freezer farm facility for vaccine storage and supply

14 March 202314 March 2023

SOUTH AFRICA – Pfizer and Biovac have launched a freezer farm facility which will serve as an ultracold storage facility and add to the institute’s capacity for vaccine storage and…

Read More

Pfizer’s Zavzpret nasal spray granted FDA approval for migraine treatment

14 March 202314 March 2023

USA — The U.S. Food and Drug Administration (FDA) has approved Pfizer’s Zavzpret (zavegepant) for the acute treatment of migraine in adult patients with or without aura. As the first…

Read More

Pfizer to acquire Seagen for US$43B in long-awaited M&A deal

13 March 202313 March 2023

USA —Pfizer has agreed to acquire Seagen, a Seattle-based biotechnology company that develops novel tumor-killing medicine, for US$43 billion in one of the biggest deals in the biotech industry in…

Read More

Pfizer and GSK on track to release highly anticipated RSV vaccines this year

12 March 202313 March 2023

USA —According to recent reports by Reuters, Pfizer, a US-based pharmaceutical company, has developed a vaccine for respiratory syncytial virus (RSV) and is prepared to launch it pending regulatory approval.…

Read More

Pfizer partners with Samsung Bio for drug substance manufacturing until 2029

7 March 20238 March 2023

SOUTH KOREA — Samsung Biologics, a contract development and manufacturing organization (CDMO), has signed a biologics supply contract with pharma giant Pfizer worth KRW 241 billion (US$183 million) and it…

Read More

Violations of Good Clinical Practices force Pfizer and Valneva to halve number of participants in Lyme disease vaccine trial

20 February 202321 February 2023

USA — Pfizer and Valneva are dropping roughly half of the 7,000 total participants enrolled in the Phase III trial of the experimental Lyme disease vaccine VLA15 in the U.S.…

Read More

Pfizer retains EU Parliament access amid vaccine purchase controversy

20 February 202321 February 2023

BELGIUM — Pfizer representatives will maintain their access to the European Parliament, despite facing possible expulsion amidst the ongoing controversy surrounding the purchase of COVID-19 vaccines. According to EurActiv, the…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.